Showing results (401-410 of 429) with videos related to
Sort By:
Pageof 43
Breast Cancer Research and Treatment|August 22, 2014
Phosphorylation of activating transcription factor-2 (ATF-2) within the activation domain is a key determinant of sensitivity to tamoxifen in breast cancerBharath Rudraraju, Marjolein Droog, Tarek M A Abdel-Fatah, et al.Cell Reports|September 29, 2015
APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast CancerManikandan Periyasamy, Hetal Patel, Chun-Fui Lai, et al.International Journal of Particle Therapy|November 1, 2021
Consensus Statement on Proton Therapy for Prostate CancerCurtis M Bryant, Randal H Henderson, R Charles Nichols, et al.Breast Cancer Research and Treatment|May 17, 2018
Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancerErik J Blok, Charla C Engels, Geeske Dekker-Ensink, et al.JCO Precision Oncology|December 1, 2021
Circulating Tumor DNA Profiling From Breast Cancer Screening Through to Metastatic DiseaseKaren Page, Luke J Martinson, Daniel Fernandez-Garcia, et al.Breast Cancer Research and Treatment|June 7, 2021
Comparison of two targeted ultra-deep sequencing technologies for analysis of plasma circulating tumour DNA in endocrine-therapy-resistant breast cancer patientsGeorgios Nteliopoulos, Karen Page, Allison Hills, et al.Journal of the National Cancer Institute|October 1, 2011
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working groupMitch Dowsett, Torsten O Nielsen, Roger A'Hern, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2017
Long-Term Follow-Up of the Intergroup Exemestane StudyJames P Morden, Isabel Alvarez, Gianfilippo Bertelli, et al.Oncogene|October 5, 2022
Genome engineering for estrogen receptor mutations reveals differential responses to anti-estrogens and new prognostic gene signatures for breast cancerAlison Harrod, Chun-Fui Lai, Isabella Goldsbrough, et al.The Journal of Pathology|October 27, 2025
Identification of actionable targets using DEPArray-based sorting of pure carcinoma and stromal populations from formalin-fixed paraffin-embedded tissues followed by shallow whole-genome sequencingGeorgios Nteliopoulos, Evie Wren, Amelia Rushton, et al.Pageof 43